In-House Testing: Why It Helps the Urgent Care Practices and the Patients - Verséa Diagnostics

In-House Testing: Why It Helps the Urgent Care Practices and the Patients

Increase Efficiency & Save Your Patients Money

Patient outcomes are the highest priority in all clinical facilities. Practitioners want to provide results to their patients as soon as possible, preferably within one visit. The ability to perform in-house lab testing allows everything to happen under one roof, saving everyone involved time and money. Outsourcing patients to a third-party lab does not give the patient the best experience possible and only allows more room for error. It already takes considerable effort to attend one appointment alone, so factoring in separate time for lab testing and another slot for a follow-up appointment to discuss results only means it will take longer to diagnose a potential medical problem. Even if results are favorable, everyone wants peace of mind when it comes to their health.

Another component to consider is consistency within the testing process. Keeping testing to one facility means the same individuals will handle the workflow, and if any errors occur, it will be easy to backtrack and solve the issue. With the increase in point-of-care testing over recent years, it is more important than ever to have reliable resources that offer accurate and precise results.

Economics always factors into the equation for any facility, but especially when worrying about patient outcomes in a clinical setting. What is most cost-effective for the practice will be more cost-effective for the patient, which is why outsourcing to a third-party lab is not in the best interest of anyone involved. Clinical facilities can generate more revenue to put back into their facility when they streamline the diagnosis and treatment in one interaction. The question is "Why not?"

Point-of-Care (POC) Diagnostic Testing

Whether it be infectious disease, drugs of abuse, or any other common diagnostic need, there are an array of POC tests available to create faster, more accurate workflows.

Customer Favorites

The Accula™ System from Thermo Fisher Scientific is the gold-standard rapid diagnostic platform that combines the accuracy of RT_PCR with the simplicity, convenience, and procedural familiarity of traditional rapid immunoassays. The Accula™ SARS-CoV-2 dock has received and Emergency Use Authorization (EUA) from the FDA for the detection of SARS-CoV-2 in Clinical Laboratory improvement Amendments (CLIA) Waived environments. Qualitative PCR results are available within 30 minutes and the dock can be used for up to 3,000 tests. With its compact design, it can fit in the palm of your hand with ease.

The Thermo Fisher Scientific™ Accula™ Flu A/Flu B Test is a rapid diagnostic test that combines the accuracy of RT-PCR with the simplicity, convenience, and procedural familiarity of traditional rapid immunoassays. The Accula Flu A/Flu B Test has received 510(k) clearance from the US Food and Drug Administration (FDA) for the qualitative and differential detection of influenza A and influenza B viral RNA in Clinical Laboratory Improvement Amendments (CLIA) waived environments. Designed for use with the palm sized Thermo Fisher Scientific™ Accula™ Dock, the Accula Flu A/Flu B Test provides reliable results in approximately 30 minutes. This PCR technology offers 97% sensitivity and 94% specificity for Flu A; 94% sensitivity and 99% specificity for Flu B.

The Accula™ SARS-CoV-2 Tests possesses similar qualities to those of the Flu A/Flu B test. With RT-PCR results in 30 minutes and a CLIA-waived workflow, this test provides 100% positive and negative percent agreement (PPA and NPA) in a prospective clinical study.

Accula Dock+ Flu A/B Test + SARS-CoV-2

The OralTox® Rapid Oral Fluid 6 Panel Drug Test is an FDA 510(k) cleared patented device that identifies the absence or presence of illicit drugs in minutes. Oral fluid drug testing offers a minimally invasive, observed collection to detect recent drug use with results in minutes. Using oral fluid, the collector can oversee a donor as he or she collects their own oral fluid specimens, reducing the likelihood of tampering or cheating as well as a donor challenge later in the drug testing process. When speed is a high priority, OralTox offers flexibility for hiring events, job fairs, and on-site collections.

The OT-Scan™ App was designed to be used with OralTox, Premier Biotech's patented lateral flow rapid oral fluid test. The OT-Scan App automates result capturing and reporting, coupled with an easy-to-use interface. Combined, OralTox and OT-Scan provide fast, accurate, and secure results in just minutes, while eliminating manual interpretation. Available for the detection of relevant drugs of abuse, including AMP, COC, MET, OPI, PCP, THC, and more.


By Clinicians, for Clinicians

At CLIA Supply, we only work with vetted suppliers and vetted buyers. As a company owned and supported by healthcare professionals, we prefer to deal directly with manufacturers and suppliers that we feel good about using in our own practices. We understand the importance of compliance, quality, training, and service to ensure clinical products meet clinical standards.

We want to help you provide the best patient outcomes possible with our highly innovative diagnostic technology. To get connected with a highly trained sales specialist, call us at 1-800-397-0670 or send us a message.

Back to blog